Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Therapeutic lumbar puncture for headache in idiopathic intracranial hypertension: Minimal gain, is it worth the pain?

Yiangou A, Mitchell J, Markey KA, Scotton W, Nightingale P, Botfield H, Ottridge R, Mollan SP, Sinclair AJ.

Cephalalgia. 2018 Jan 1:333102418782192. doi: 10.1177/0333102418782192. [Epub ahead of print]

PMID:
29911422
2.

Conventional dendritic cells are required for the cross-presentation of leukemia-specific antigen in a model of AML relapse post-BMT.

Markey KA, Gartlan KH, Kuns RD, Lane SW, Hill GR.

Bone Marrow Transplant. 2018 Jun;53(6):800-803. doi: 10.1038/s41409-018-0148-y. Epub 2018 Mar 13. No abstract available.

PMID:
29535380
3.

Early Blood Stream Infections after BMT are Associated with Cytokine Dysregulation and Poor Overall Survival.

Catchpoole EM, Thirunavukarasu CE, Varelias A, Schlebusch S, Olver S, Zomerdijk N, Osland E, Kennedy GA, Tey SK, Hill GR, Markey KA.

Biol Blood Marrow Transplant. 2018 Jul;24(7):1360-1366. doi: 10.1016/j.bbmt.2018.02.025. Epub 2018 Mar 5.

PMID:
29518552
4.

Flt-3L Expansion of Recipient CD8α+ Dendritic Cells Deletes Alloreactive Donor T Cells and Represents an Alternative to Posttransplant Cyclophosphamide for the Prevention of GVHD.

Markey KA, Kuns RD, Browne DJ, Gartlan KH, Robb RJ, Martins JP, Henden AS, Minnie SA, Cheong M, Koyama M, Smyth MJ, Steptoe RJ, Belz GT, Brocker T, Degli-Esposti MA, Lane SW, Hill GR.

Clin Cancer Res. 2018 Apr 1;24(7):1604-1616. doi: 10.1158/1078-0432.CCR-17-2148. Epub 2018 Jan 24.

PMID:
29367429
5.

Development of a Multiplexed Microsphere PCR for Culture-Free Detection and Gram-Typing of Bacteria in Human Blood Samples.

Liang F, Browne DJ, Gray MJ, Gartlan KH, Smith DD, Barnard RT, Hill GR, Corrie SR, Markey KA.

ACS Infect Dis. 2018 May 11;4(5):837-844. doi: 10.1021/acsinfecdis.7b00277. Epub 2018 Jan 31.

PMID:
29350524
6.

Segmentation error in spectral domain optical coherence tomography measures of the retinal nerve fibre layer thickness in idiopathic intracranial hypertension.

Aojula A, Mollan SP, Horsburgh J, Yiangou A, Markey KA, Mitchell JL, Scotton WJ, Keane PA, Sinclair AJ.

BMC Ophthalmol. 2018 Jan 4;17(1):257. doi: 10.1186/s12886-017-0652-7.

7.

Th17 plasticity and transition toward a pathogenic cytokine signature are regulated by cyclosporine after allogeneic SCT.

Gartlan KH, Varelias A, Koyama M, Robb RJ, Markey KA, Chang K, Wilkinson AN, Smith D, Ullah MA, Kuns RD, Raffelt NC, Olver SD, Lineburg KE, Teal BE, Cheong M, Teng MWL, Smyth MJ, Tey SK, MacDonald KPA, Hill GR.

Blood Adv. 2017 Jan 26;1(6):341-351. doi: 10.1182/bloodadvances.2016002980. eCollection 2017 Feb 14.

8.

What Do Transgender Patients Teach Us About Idiopathic Intracranial Hypertension?

Hornby C, Mollan SP, Mitchell J, Markey KA, Yangou A, Wright BLC, O'Reilly MW, Sinclair AJ.

Neuroophthalmology. 2017 May 10;41(6):326-329. doi: 10.1080/01658107.2017.1316744. eCollection 2017.

9.

Interleukin-12 from CD103+ Batf3-Dependent Dendritic Cells Required for NK-Cell Suppression of Metastasis.

Mittal D, Vijayan D, Putz EM, Aguilera AR, Markey KA, Straube J, Kazakoff S, Nutt SL, Takeda K, Hill GR, Waddell N, Smyth MJ.

Cancer Immunol Res. 2017 Dec;5(12):1098-1108. doi: 10.1158/2326-6066.CIR-17-0341. Epub 2017 Oct 25.

PMID:
29070650
10.
11.

Low rates of antibiotic resistance and infectious mortality in a cohort of high-risk hematology patients: A single center, retrospective analysis of blood stream infection.

Conn JR, Catchpoole EM, Runnegar N, Mapp SJ, Markey KA.

PLoS One. 2017 May 19;12(5):e0178059. doi: 10.1371/journal.pone.0178059. eCollection 2017.

12.

Rates of neutropenia in adults with influenza A or B: a retrospective analysis of hospitalised patients in South East Queensland during 2015.

Higgins P, Runnegar N, Bird RJ, Markey KA.

Intern Med J. 2016 Nov;46(11):1328-1332. doi: 10.1111/imj.13239.

PMID:
27813353
13.

Corruption of dendritic cell antigen presentation during acute GVHD leads to regulatory T-cell failure and chronic GVHD.

Leveque-El Mouttie L, Koyama M, Le Texier L, Markey KA, Cheong M, Kuns RD, Lineburg KE, Teal BE, Alexander KA, Clouston AD, Blazar BR, Hill GR, MacDonald KP.

Blood. 2016 Aug 11;128(6):794-804. doi: 10.1182/blood-2015-11-680876. Epub 2016 Jun 23.

14.

Idiopathic intracranial hypertension, hormones, and 11β-hydroxysteroid dehydrogenases.

Markey KA, Uldall M, Botfield H, Cato LD, Miah MA, Hassan-Smith G, Jensen RH, Gonzalez AM, Sinclair AJ.

J Pain Res. 2016 Apr 19;9:223-32. doi: 10.2147/JPR.S80824. eCollection 2016. Review.

15.

Understanding idiopathic intracranial hypertension: mechanisms, management, and future directions.

Markey KA, Mollan SP, Jensen RH, Sinclair AJ.

Lancet Neurol. 2016 Jan;15(1):78-91. doi: 10.1016/S1474-4422(15)00298-7. Epub 2015 Dec 8. Review.

PMID:
26700907
16.

Tc17 cells are a proinflammatory, plastic lineage of pathogenic CD8+ T cells that induce GVHD without antileukemic effects.

Gartlan KH, Markey KA, Varelias A, Bunting MD, Koyama M, Kuns RD, Raffelt NC, Olver SD, Lineburg KE, Cheong M, Teal BE, Lor M, Comerford I, Teng MW, Smyth MJ, McCluskey J, Rossjohn J, Stockinger B, Boyle GM, Lane SW, Clouston AD, McColl SR, MacDonald KP, Hill GR.

Blood. 2015 Sep 24;126(13):1609-20. doi: 10.1182/blood-2015-01-622662. Epub 2015 Jul 23.

17.

Donor colonic CD103+ dendritic cells determine the severity of acute graft-versus-host disease.

Koyama M, Cheong M, Markey KA, Gartlan KH, Kuns RD, Locke KR, Lineburg KE, Teal BE, Leveque-El Mouttie L, Bunting MD, Vuckovic S, Zhang P, Teng MW, Varelias A, Tey SK, Wockner LF, Engwerda CR, Smyth MJ, Belz GT, McColl SR, MacDonald KP, Hill GR.

J Exp Med. 2015 Jul 27;212(8):1303-21. doi: 10.1084/jem.20150329. Epub 2015 Jul 13.

18.

Headache determines quality of life in idiopathic intracranial hypertension.

Mulla Y, Markey KA, Woolley RL, Patel S, Mollan SP, Sinclair AJ.

J Headache Pain. 2015;16:521. doi: 10.1186/s10194-015-0521-9. Epub 2015 May 15.

19.

Imaging the immunological synapse between dendritic cells and T cells.

Markey KA, Gartlan KH, Kuns RD, MacDonald KP, Hill GR.

J Immunol Methods. 2015 Aug;423:40-4. doi: 10.1016/j.jim.2015.04.029. Epub 2015 May 9.

PMID:
25967948
20.

Blood, sweat, and tears: developing clinically relevant protein biosensors for integrated body fluid analysis.

Corrie SR, Coffey JW, Islam J, Markey KA, Kendall MA.

Analyst. 2015 Jul 7;140(13):4350-64. doi: 10.1039/c5an00464k. Review.

PMID:
25909342
21.

Lung parenchyma-derived IL-6 promotes IL-17A-dependent acute lung injury after allogeneic stem cell transplantation.

Varelias A, Gartlan KH, Kreijveld E, Olver SD, Lor M, Kuns RD, Lineburg KE, Teal BE, Raffelt NC, Cheong M, Alexander KA, Koyama M, Markey KA, Sturgeon E, Leach J, Reddy P, Kennedy GA, Yanik GA, Blazar BR, Tey SK, Clouston AD, MacDonald KP, Cooke KR, Hill GR.

Blood. 2015 Apr 9;125(15):2435-44. doi: 10.1182/blood-2014-07-590232. Epub 2015 Feb 11.

22.

CSF-1-dependant donor-derived macrophages mediate chronic graft-versus-host disease.

Alexander KA, Flynn R, Lineburg KE, Kuns RD, Teal BE, Olver SD, Lor M, Raffelt NC, Koyama M, Leveque L, Le Texier L, Melino M, Markey KA, Varelias A, Engwerda C, Serody JS, Janela B, Ginhoux F, Clouston AD, Blazar BR, Hill GR, MacDonald KP.

J Clin Invest. 2014 Oct;124(10):4266-80. doi: 10.1172/JCI75935. Epub 2014 Aug 26.

23.

The biology of graft-versus-host disease: experimental systems instructing clinical practice.

Markey KA, MacDonald KP, Hill GR.

Blood. 2014 Jul 17;124(3):354-62. doi: 10.1182/blood-2014-02-514745. Epub 2014 Jun 9. Review.

24.

A practical approach to, diagnosis, assessment and management of idiopathic intracranial hypertension.

Mollan SP, Markey KA, Benzimra JD, Jacks A, Matthews TD, Burdon MA, Sinclair AJ.

Pract Neurol. 2014 Dec;14(6):380-90. doi: 10.1136/practneurol-2014-000821. Epub 2014 May 8. Review.

25.

Cross-dressing by donor dendritic cells after allogeneic bone marrow transplantation contributes to formation of the immunological synapse and maximizes responses to indirectly presented antigen.

Markey KA, Koyama M, Gartlan KH, Leveque L, Kuns RD, Lineburg KE, Teal BE, MacDonald KP, Hill GR.

J Immunol. 2014 Jun 1;192(11):5426-33. doi: 10.4049/jimmunol.1302490. Epub 2014 Apr 30.

26.

Modification of T cell responses by stem cell mobilization requires direct signaling of the T cell by G-CSF and IL-10.

MacDonald KP, Le Texier L, Zhang P, Morris H, Kuns RD, Lineburg KE, Leveque L, Don AL, Markey KA, Vuckovic S, Bagger FO, Boyle GM, Blazar BR, Hill GR.

J Immunol. 2014 Apr 1;192(7):3180-9. doi: 10.4049/jimmunol.1302315. Epub 2014 Feb 28.

27.

Should we educate about the risks of medication overuse headache?

Lai JT, Dereix JD, Ganepola RP, Nightingale PG, Markey KA, Aveyard PN, Sinclair AJ.

J Headache Pain. 2014 Feb 13;15:10. doi: 10.1186/1129-2377-15-10.

28.

Induced regulatory T cells promote tolerance when stabilized by rapamycin and IL-2 in vivo.

Zhang P, Tey SK, Koyama M, Kuns RD, Olver SD, Lineburg KE, Lor M, Teal BE, Raffelt NC, Raju J, Leveque L, Markey KA, Varelias A, Clouston AD, Lane SW, MacDonald KP, Hill GR.

J Immunol. 2013 Nov 15;191(10):5291-303. doi: 10.4049/jimmunol.1301181. Epub 2013 Oct 11.

29.

Promoting regulation via the inhibition of DNAM-1 after transplantation.

Koyama M, Kuns RD, Olver SD, Lineburg KE, Lor M, Teal BE, Raffelt NC, Leveque L, Chan CJ, Robb RJ, Markey KA, Alexander KA, Varelias A, Clouston AD, Smyth MJ, MacDonald KP, Hill GR.

Blood. 2013 Apr 25;121(17):3511-20. doi: 10.1182/blood-2012-07-444026. Epub 2013 Feb 21.

30.

CD8α+ DCs can be induced in the absence of transcription factors Id2, Nfil3, and Batf3.

Seillet C, Jackson JT, Markey KA, Brady HJ, Hill GR, Macdonald KP, Nutt SL, Belz GT.

Blood. 2013 Feb 28;121(9):1574-83. doi: 10.1182/blood-2012-07-445650. Epub 2013 Jan 7.

31.

Identification and expansion of highly suppressive CD8(+)FoxP3(+) regulatory T cells after experimental allogeneic bone marrow transplantation.

Robb RJ, Lineburg KE, Kuns RD, Wilson YA, Raffelt NC, Olver SD, Varelias A, Alexander KA, Teal BE, Sparwasser T, Hammerling GJ, Markey KA, Koyama M, Clouston AD, Engwerda CR, Hill GR, MacDonald KP.

Blood. 2012 Jun 14;119(24):5898-908. doi: 10.1182/blood-2011-12-396119. Epub 2012 Apr 26.

32.

Immune insufficiency during GVHD is due to defective antigen presentation within dendritic cell subsets.

Markey KA, Koyama M, Kuns RD, Lineburg KE, Wilson YA, Olver SD, Raffelt NC, Don AL, Varelias A, Robb RJ, Cheong M, Engwerda CR, Steptoe RJ, Ramshaw HS, Lopez AF, Vega-Ramos J, Lew AM, Villadangos JA, Hill GR, MacDonald KP.

Blood. 2012 Jun 14;119(24):5918-30. doi: 10.1182/blood-2011-12-398164. Epub 2012 Mar 13.

33.

Recipient nonhematopoietic antigen-presenting cells are sufficient to induce lethal acute graft-versus-host disease.

Koyama M, Kuns RD, Olver SD, Raffelt NC, Wilson YA, Don AL, Lineburg KE, Cheong M, Robb RJ, Markey KA, Varelias A, Malissen B, Hämmerling GJ, Clouston AD, Engwerda CR, Bhat P, MacDonald KP, Hill GR.

Nat Med. 2011 Nov 29;18(1):135-42. doi: 10.1038/nm.2597.

PMID:
22127134
34.

Type I-IFNs control GVHD and GVL responses after transplantation.

Robb RJ, Kreijveld E, Kuns RD, Wilson YA, Olver SD, Don AL, Raffelt NC, De Weerd NA, Lineburg KE, Varelias A, Markey KA, Koyama M, Clouston AD, Hertzog PJ, Macdonald KP, Hill GR.

Blood. 2011 Sep 22;118(12):3399-409. doi: 10.1182/blood-2010-12-325746. Epub 2011 Jun 30.

35.

SOCS3 regulates graft-versus-host disease.

Hill GR, Kuns RD, Raffelt NC, Don AL, Olver SD, Markey KA, Wilson YA, Tocker J, Alexander WS, Clouston AD, Roberts AW, MacDonald KP.

Blood. 2010 Jul 15;116(2):287-96. doi: 10.1182/blood-2009-12-259598. Epub 2010 Apr 30.

36.

Stem cell mobilization with G-CSF induces type 17 differentiation and promotes scleroderma.

Hill GR, Olver SD, Kuns RD, Varelias A, Raffelt NC, Don AL, Markey KA, Wilson YA, Smyth MJ, Iwakura Y, Tocker J, Clouston AD, Macdonald KP.

Blood. 2010 Aug 5;116(5):819-28. doi: 10.1182/blood-2009-11-256495. Epub 2010 Apr 30.

37.

Soluble lymphotoxin is an important effector molecule in GVHD and GVL.

Markey KA, Burman AC, Banovic T, Kuns RD, Raffelt NC, Rowe V, Olver SD, Don AL, Morris ES, Pettit AR, Wilson YA, Robb RJ, Randall LM, Korner H, Engwerda CR, Clouston AD, Macdonald KP, Hill GR.

Blood. 2010 Jan 7;115(1):122-32. doi: 10.1182/blood-2009-01-199927. Epub 2009 Sep 29.

38.

Recipient plasmacytoid DCs are not required to prime allogeneic T-cell responses after BMT.

Markey KA, MacDonald KP, Hill GR.

Blood. 2009 Jun 4;113(23):6038-9. doi: 10.1182/blood-2009-03-212944. No abstract available.

39.

Invariant natural killer T cell-natural killer cell interactions dictate transplantation outcome after alpha-galactosylceramide administration.

Kuns RD, Morris ES, Macdonald KP, Markey KA, Morris HM, Raffelt NC, Banovic T, Don AL, Rowe V, Burman AC, Clouston AD, Farah C, Besra GS, Illarionov PA, Smyth MJ, Porcelli SA, Hill GR.

Blood. 2009 Jun 4;113(23):5999-6010. doi: 10.1182/blood-2008-10-183335. Epub 2009 Apr 15.

40.

Conventional dendritic cells are the critical donor APC presenting alloantigen after experimental bone marrow transplantation.

Markey KA, Banovic T, Kuns RD, Olver SD, Don AL, Raffelt NC, Wilson YA, Raggatt LJ, Pettit AR, Bromberg JS, Hill GR, MacDonald KP.

Blood. 2009 May 28;113(22):5644-9. doi: 10.1182/blood-2008-12-191833. Epub 2009 Mar 31.

41.

Induction of natural killer T cell-dependent alloreactivity by administration of granulocyte colony-stimulating factor after bone marrow transplantation.

Morris ES, MacDonald KP, Kuns RD, Morris HM, Banovic T, Don AL, Rowe V, Wilson YA, Raffelt NC, Engwerda CR, Burman AC, Markey KA, Godfrey DI, Smyth MJ, Hill GR.

Nat Med. 2009 Apr;15(4):436-41. doi: 10.1038/nm.1948. Epub 2009 Mar 29.

PMID:
19330008
42.

Donor treatment with a multipegylated G-CSF maximizes graft-versus-leukemia effects.

Banovic T, MacDonald KP, Markey KA, Morris ES, Kuns RD, Varelias A, Hill GR.

Biol Blood Marrow Transplant. 2009 Jan;15(1):126-30. doi: 10.1016/j.bbmt.2008.11.019.

43.

Graft-versus-host disease prevents the maturation of plasmacytoid dendritic cells.

Banovic T, Markey KA, Kuns RD, Olver SD, Raffelt NC, Don AL, Degli-Esposti MA, Engwerda CR, MacDonald KP, Hill GR.

J Immunol. 2009 Jan 15;182(2):912-20. Erratum in: J Immunol. 2009 Mar 1;182(5):3327.

44.

Impact of cytokine gene polymorphisms on graft-vs-host disease.

Markey KA, MacDonald KP, Hill GR.

Tissue Antigens. 2008 Dec;72(6):507-16. doi: 10.1111/j.1399-0039.2008.01139.x. Epub 2008 Sep 29. Review. Erratum in: Tissue Antigens. 2009 Feb;73(2):192.

PMID:
19000150
45.

Effector and regulatory T-cell function is differentially regulated by RelB within antigen-presenting cells during GVHD.

MacDonald KP, Kuns RD, Rowe V, Morris ES, Banovic T, Bofinger H, O'Sullivan B, Markey KA, Don AL, Thomas R, Hill GR.

Blood. 2007 Jun 1;109(11):5049-57. Epub 2007 Feb 27.

46.

Glucocorticoid effects on phenylethanolamine N-methyltransferase (PNMT) in explants of embryonic rat medulla oblongata.

Bohn MC, Dreyfus CF, Friedman WJ, Markey KA.

Brain Res. 1987 Dec 15;465(1-2):257-66.

PMID:
3440206
47.

Depolarizing stimuli increase tyrosine hydroxylase in the mouse locus coeruleus in culture.

Dreyfus CF, Friedman WJ, Markey KA, Black IB.

Brain Res. 1986 Aug 6;379(2):216-22.

PMID:
2874868
48.
49.

Influence of ACTH on tyrosine hydroxylase activity in the locus coeruleus of mouse brain.

Markey KA, Sze PY.

Neuroendocrinology. 1984 Apr;38(4):269-75.

PMID:
6145110
50.

Transient expression of selected catecholaminergic traits in cranial sensory and dorsal root ganglia of the embryonic rat.

Jonakait GM, Markey KA, Goldstein M, Black IB.

Dev Biol. 1984 Jan;101(1):51-60.

PMID:
6141117

Supplemental Content

Loading ...
Support Center